Source: European Medicines Agency (EU) Revision Year: 2020 Publisher: medac, Gesellschaft für klinische Spezialpräparate mbH, Theaterstr. 6, 22880, Wedel, Germany
Trecondi 1 g powder for solution for infusion.
Trecondi 5 g powder for solution for infusion.
Pharmaceutical Form |
---|
Powder for solution for infusion. White crystalline powder. |
Trecondi 1 g powder for solution for infusion: One vial contains 1 g of treosulfan.
Trecondi 5 g powder for solution for infusion: One vial contains 5 g of treosulfan.
When reconstituted according to section 6.6, 1 mL of the solution for infusion contains 50 mg treosulfan.
Active Ingredient | Description | |
---|---|---|
Treosulfan |
Treosulfan is a prodrug of a bifunctional alkylating agent with cytotoxic activity to haematopoietic precursor cells. The activity of treosulfan is due to the spontaneous conversion into a mono-epoxide intermediate and L-diepoxybutan. Treosulfan has a broad antineoplastic and antileukaemic activity. |
List of Excipients |
---|
None. |
Trecondi 1 g powder for solution for infusion: Colourless type III glass vial, with rubber stopper and aluminium cap containing 1 g of treosulfan.
Trecondi 5 g powder for solution for infusion: Colourless type III glass vial, with rubber stopper and aluminium cap containing 5 g of treosulfan.
Trecondi is available in packs of 1 or 5 vials.
Not all pack sizes may be marketed.
medac, Gesellschaft für klinische Spezialpräparate mbH, Theaterstr. 6, 22880, Wedel, Germany
EU/1/18/1351/001 (1 g, 1 vial)
EU/1/18/1351/002 (1 g, 5 vials)
EU/1/18/1351/003 (5 g, 1 vial)
EU/1/18/1351/004 (5 g, 5 vials)
Date of first authorisation: 20 June 2019
Drug | Countries | |
---|---|---|
TRECONDI | Austria, Estonia, Spain, Finland, France, Croatia, Ireland, Italy, Lithuania, Netherlands, Poland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.